title: Melanoma brain metastases: is it time to reassess the bias?
authors.forename: Jaclyn C
authors.initials: JC
authors.lastname: Flanigan
authors.forename: Lucia B
authors.initials: LB
authors.lastname: Jilaveanu
authors.forename: Mark
authors.initials: M
authors.lastname: Faries
authors.forename: Mario
authors.initials: M
authors.lastname: Sznol
authors.forename: Stephan
authors.initials: S
authors.lastname: Ariyan
authors.forename: James B
authors.initials: JB
authors.lastname: Yu
authors.forename: Jonathan P S
authors.initials: JP
authors.lastname: Knisely
authors.forename: Veronica L
authors.initials: VL
authors.lastname: Chiang
authors.forename: Harriet M
authors.initials: HM
authors.lastname: Kluger
mesh_terms: D000328:Adult; D001812:Blood-Brain Barrier; D001932:Brain Neoplasms / Q000401:mortality / Q000473:pathology / Q000556:secondary*; D015331:Cohort Studies; D005260:Female; D006801:Humans; D008297:Male; D008545:Melanoma / Q000401:mortality / Q000473:pathology / Q000556:secondary*; D008875:Middle Aged; D016066:Pleural Effusion, Malignant / Q000401:mortality; D011379:Prognosis; D016019:Survival Analysis